CJC-1295 (No DAC) + Ipamorelin also written CJC 1295 or CJC1295 is a dual-peptide research formulation that pairs a short-acting GHRH analogue (CJC-1295 No DAC) with a selective growth-hormone-releasing peptide (Ipamorelin, a ghrelin/GHS-receptor agonist)
Furthermore, CSF can be tested serially, allowing for the study of protein changes reflecting the evolving pathology throughout the disease's clinical course
The second cause for concern stemming from an increased use is patients access
That said, planning nutrient-dense meals around your dosing window can help reduce appetite later
This includes cognitive behavioral therapy for eating disorders (CBT-E), exposure and response prevention (ERP), dialectical behavior therapy (DBT), acceptance and commitment therapy (ACT), and family-based treatment (FBT)
Consult a Healthcare Professional Before starting any supplementation regimen, we encourage you to consult with a healthcare professional